Description
As mental health challenges continue to rise, researchers and practitioners are revisiting a controversial question: could psychedelics play a role in modern therapy?
Once confined to counterculture movements, substances such as psilocybin and LSD are now the focus of serious scientific research. Early studies suggest potential in treating depression, PTSD and addiction, yet concerns remain around safety, ethics and regulation.
Bringing together voices from research and practice, we explore the evidence behind psychedelic therapy, the risks involved and what their growing mainstream interest means for the future of mental healthcare. Are psychedelics a breakthrough in treatment, a cultural trend or something more complex?
About the Academic
Dr David Luke
David Luke is Professor of Exceptional Experience at the University of Greenwich, UK, where he leads the Psychedelic and Exceptional Experience Lab, and is a current Perrott-Warrick Senior Researcher (via Trinity College, Cambridge) researching altered states and psi. His research focuses on transpersonal experiences, anomalous phenomena and altered states of consciousness.
About the Speaker
Sarah Tilley
Sarah Tilley is a therapist specialising in relationships, intimacy and generational trauma, and a pioneer in psychedelic-assisted couple’s therapy. Tilley is founder of Beautiful Space and creator of the Beautiful Space Method™, integrating psychedelics, somatic practice and relational psychology. With over 20 years’ clinical experience, Tilley is an international speaker, currently collaborating with Imperial College London on research into psilocybin and relationship wellbeing, and writing her first book, Rewilding, Psychedelics and the architecture of inherited trauma.
Join Our Mailing List
By submitting this form you agree to our Privacy Policy and to receive marketing emails, including e-newsletters and event updates from Bradford Literature Festival.